Logo image of BLDS.CA

BADLANDS RESOURCES INC (BLDS.CA) Stock Fundamental Analysis

TSX-V:BLDS - TSX Venture Exchange - CA0566001099 - Common Stock - Currency: CAD

0.15  -0.01 (-3.23%)

Fundamental Rating

1

BLDS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 822 industry peers in the Metals & Mining industry. Both the profitability and financial health of BLDS have multiple concerns. BLDS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BLDS has reported negative net income.
BLDS had a negative operating cash flow in the past year.
BLDS had negative earnings in each of the past 5 years.
BLDS had a negative operating cash flow in each of the past 5 years.
BLDS.CA Yearly Net Income VS EBIT VS OCF VS FCFBLDS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

BLDS has a better Return On Assets (-7.68%) than 66.06% of its industry peers.
BLDS has a Return On Equity of -9.99%. This is in the better half of the industry: BLDS outperforms 65.82% of its industry peers.
Industry RankSector Rank
ROA -7.68%
ROE -9.99%
ROIC N/A
ROA(3y)-7.62%
ROA(5y)-9.53%
ROE(3y)-8.76%
ROE(5y)-10.73%
ROIC(3y)N/A
ROIC(5y)N/A
BLDS.CA Yearly ROA, ROE, ROICBLDS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BLDS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLDS.CA Yearly Profit, Operating, Gross MarginsBLDS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for BLDS has been increased compared to 1 year ago.
The number of shares outstanding for BLDS has been increased compared to 5 years ago.
BLDS has a worse debt/assets ratio than last year.
BLDS.CA Yearly Shares OutstandingBLDS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
BLDS.CA Yearly Total Debt VS Total AssetsBLDS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -5.31, we must say that BLDS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BLDS (-5.31) is worse than 63.39% of its industry peers.
BLDS has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
BLDS has a Debt to Equity ratio (0.05) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -5.31
ROIC/WACCN/A
WACCN/A
BLDS.CA Yearly LT Debt VS Equity VS FCFBLDS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

BLDS has a Current Ratio of 0.03. This is a bad value and indicates that BLDS is not financially healthy enough and could expect problems in meeting its short term obligations.
BLDS has a Current ratio of 0.03. This is amonst the worse of the industry: BLDS underperforms 85.94% of its industry peers.
A Quick Ratio of 0.03 indicates that BLDS may have some problems paying its short term obligations.
The Quick ratio of BLDS (0.03) is worse than 85.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
BLDS.CA Yearly Current Assets VS Current LiabilitesBLDS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.11% over the past year.
EPS 1Y (TTM)17.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLDS.CA Yearly Revenue VS EstimatesBLDS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
BLDS.CA Yearly EPS VS EstimatesBLDS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLDS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLDS.CA Price Earnings VS Forward Price EarningsBLDS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLDS.CA Per share dataBLDS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BLDS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BADLANDS RESOURCES INC

TSX-V:BLDS (3/5/2025, 7:00:00 PM)

0.15

-0.01 (-3.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.61%
Ins Owner ChangeN/A
Market Cap1.70M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.19
P/tB 0.19
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.78
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.68%
ROE -9.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.62%
ROA(5y)-9.53%
ROE(3y)-8.76%
ROE(5y)-10.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 712.09%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -5.31
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)436.8%
Cap/Depr(5y)1751.32%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.52%
OCF growth 3YN/A
OCF growth 5YN/A